Galena Biopharma Inc. (Nasdaq: GALE) disclosed that the Securities and Exchange Commission was investigating the company for engaging in a stock promotion campaign. The stock price fell 35 cents to $2.87.
SEC Investigates Galena Biopharma
March 18, 2014 at 12:54 PM EDT